李妍

助理教授 |生命科学学院, 系统生物学系

李妍博士长期从事人类恶性肿瘤的表观遗传学与表观转录组学研究,研究兴趣集中于寻找与肝癌、食道癌及结直肠癌发生相关的基因;探讨RNA编辑、RNA可变剪接等表观转录调控在肿瘤发生发展中的作用;解析肿瘤干细胞及肿瘤微环境调控机制等几个方面。近年在SCI收录的国际杂志上发表高水平论文三十余篇,包括NatureMedicine、Gastroenterology、Oncogene等杂志,SCI他引超过1600次。

个人简介

教育经历:

2008年9月-2012年11月           香港大学,临床肿瘤系,博士学位            

2004年9月-2008年6月           中山大学,生物技术专业,本科学位

 

工作经历:

2016年5月-至今                              南方科技大学,生物系,助理教授

2013年2月-2016年2月                  香港大学,临床肿瘤系,博士后研究员

 

主要荣誉

2017:广东省珠江人才创新创业团队核心成员

2017:深圳市孔雀人才计划C类

2014:国家教育部高等学校科学研究优秀成果奖(自然科学二等奖),第四完成人

2014:香港大学李嘉诚医学院杰出研究成果奖。

2013:香港科学会2013香港青年科学家奖(生命科学组)

2013:香港大学李嘉诚医学院Dr KP Stephen Chang Gold Medal

2012:香港大学李嘉诚奖

2007:中山大学蒲蜇龙学者科学基金奖

 

研究领域

1. 鉴定肝癌、食道癌及结直肠癌发生相关的基因

2. 探讨RNA编辑、RNA可变剪接等表观转录调控在肿瘤发生发展中的作用

3. 解析肿瘤干细胞及肿瘤微环境调控机制


教学

普通生物学

生命科学概论

Advanced Biological Sciences


学术成果 查看更多

代表性论文:

  1. Zheng J, Wu S, Tang M, Xi S, Wang Y, Ren J, Luo H, Hu P, Sun L, Du Y, Yang H, Wang F, Gao H, Dai Z, Ou X, Li Y*. USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC. Cell Death & Disease. 2023 Oct 11;14(10):670. (影响因子: 9.0)
  2. Wang Y, Hu P, Wang F, Xi S, Wu S, Sun L, Du Y, Zheng J, Yang H, Tang M, Gao H, Luo H, Lv Y, Yan J, Ou X, Li Y*. UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma. Cell Death & Disease. 2023 Jun 28;14(6):381. (影响因子: 9.0)
  3. Li Y, Ruan GX, Chen W, Huang H, Zhang R, Wang J, Li Y*, Xu S, Ou X*. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response. Journal of Immunology. 2022 Aug 17;ji2200149. (*:共同通讯作者) (影响因子: 4.4)
  4. Sun L, Xi S, Zhou Z, Zhang F, Hu P, Cui Y, Wu S, Wang Y, Wu S, Wang Y, Du Y, Zheng J, Yang H, Chen M, Yan Q, Yu D, Shi C, Zhang Y, Xie D, Guan XY*, Li Y*. Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor. Oncogene. 2022 Jan;41(5):732-744. (*:共同通讯作者) (影响因子: 8.0)
  5. Li Q, Sun H, Luo D, Gan L, Mo S, Dai W, Liang L, Yang Y, Xu M, Li J, Zheng P, Li X*, Li Y*, Wang Z*. Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. J Exp Clin Cancer Res. 2021 Nov 5;40(1):348. (*:共同通讯作者) (影响因子: 11.3)
  6. Lu J, Hu P, Cao L, Wei Z, Xiao F, Chen Z, Li Y*, Tian L*. Genetically Encoded and Biologically Produced All-DNA Nanomedicine Based on One-Pot Assembly of DNA Dendrimers for Targeted Gene Regulation. Angewandte Chemie-International Edition. 2021 Mar 1;60(10):5377-5385. (*:共同通讯作者) (影响因子: 16.6)
  7. Wang Z, Yan M, Li J, Long J, Li Y*, Zhang H*. Dual functions of STAT3 in LPS-induced angiogenesis of hepatocellular carcinoma. Biochimica et Biophysica Acta-Molecular Cell Research. 2019 Apr;1866(4):566-574. (*:共同通讯作者) (影响因子: 5.1)
  8. Li Y, Chen L, Chan TH, Guan XY. Hepatocellular Carcinoma: Transcriptome diversity regulated by RNA editing. International Journal of Biochemistry & Cell Biology. 2013 Aug;45(8):1843-8. (影响因子: 4.0)
  9. Chen LL*, Li Y*, Chi HL, Liu M, Song YY, Chan TH, Yuan YF, Chow RKK, Fu L, Kong KL, Zhang N, Tong AHY, Kwong DLW, Man K, Lo CM, Lok S, Tenen DG, Guan XY. Recoding RNA editing of antizyme inhibitor 1 predisposes to hepatocellular carcinoma. Nature Medicine. 2013 Feb;19(2):209-16. (*:共同第一作者) (影响因子: 82.9)
  10. Li Y, Chen LL, Chan TH, Liu M, Kong KL, Li Y, Qiu JL, Yuan YF, Guan XY. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. Gastroenterology. 2013 Jan;144(1):179-191. (影响因子: 29.4)

    其它论文:

  11. Gao H, Zhong Y, Zhou L, Lin S, Hou X, Ding Z, Li Y, Yao Q, Cao H, Zou X, Chen D, Bai X, Xiao G. Kindlin-2 inhibits TNF/NF-κB-Caspase 8 pathway in hepatocytes to maintain liver development and function. Elife. 2023 Jan 9:12:e81792. (影响因子: 7.7)
  12. Chen W, Li Y, Ruan GX, Huang H, Zhang R, Wang J, Ouyang Y, Li Y, Xu S, Ou X. Adenosine deaminase acting on RNA-1 is essential for early B lymphopoiesis. Cell Reports. 2022 Nov 22;41(8):111687. (影响因子: 8.8)
  13. Liao L, He Y, Li SJ, Zhang GG, Yu W, Yang J, Huang ZJ, Zheng CC, He QY, Li Y, Li B. Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3. Cancer Research. 2022 Jul 5;82(13):2444-2457. (影响因子: 11.2)
  14. Chiang DC, Li Y, Ng SK. The Role of the Z-DNA Binding Domain in Innate Immunity and Stress Granules. Frontiers in Immunology. 2021 Feb 3;11:625504. (影响因子: 4.0)
  15. Wu S, Chen M, Huang J, Zhang F, Lv Z, Jia Y, Cui YZ, Sun LZ, Wang Y, Tang Y, Verhoeft KR, Li Y, Qin Y, Lin X, Guan XY, Lam KO. ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis Through PI3K/Akt Signaling and MAPK-dependent Focal Adhesion Disassembly. Cancer Research. 2021 Feb 15;81(4):986-1000. (影响因子: 11.2)
  16. Liu M, Yan Q, Sun Y, Nam Y, Hu L, Loong JH, Ouyang Q, Zhang Y, Li HL, Kong FE, Li L, Li Y, Li MM, Cheng W, Jiang LX, Fang S, Yang XD, Mo JQ, Gong YF, Tang YQ, Li Y, Yuan YF, Ma NF, Lin G, Ma S, Wang JG, Guan XY.A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets. Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6103-6113. (影响因子: 10.7)
  17. Cui Y, Zhang F, Jia Y, Sun L, Chen M, Wu S, Verhoeft K, Li Y, Qin Y, Guan X, Lam KO. The BMP antagonist, SOSTDC1, restrains gastric cancer progression via inactivation of c-Jun signaling. Am J Cancer Res. 2019 Nov 1;9(11):2331-2348. (影响因子: 5.3)
  18. Wu B, Zhang D, Nie H, Shen S, Li Y, Li S. Structure of Arabidopsis thaliana N6-methyl-AMP deaminase ADAL with bound GMP and IMP and implications for N6-methyl-AMP recognition and processing. RNA Biol. 2019 Oct;16(10):1504-1512. (影响因子: 4.1)
  19. Sin STK, Li Y, Liu M, Ma S, Guan XY.TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling. Gynecol Oncol. 2019 Jan;152(1):185-193. (影响因子: 4.7)
  20. Sin STK, Li Y, Liu M, Yuan YF, Ma S, Guan XY. Down-regulation of TROP-2 Predicts Poor Prognosis of Hepatocellular Carcinoma Patients. Hepatol Commun. 2018 Oct 2;2(11):1408-1414. (影响因子: 5.1)
  21. Li L, Li JC, Yang H, Zhang X, Liu LL, Li Y, Zeng TT, Zhu YH, Li XD, Li Y, Xie D, Fu L, Guan XY. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis. Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8948-E8957. (影响因子: 10.7)
  22. Zhao H, Yuan X, Yu J, Huang Y, Shao C, Xiao F, Lin L, Li Y, Tian L. Magnesium-Stabilized Multifunctional DNA Nanoparticles for Tumor-Targeted and pH-Responsive Drug Delivery. ACS Appl Mater Interfaces. 2018 May 9;10(18):15418-15427. (影响因子: 9.5)
  23. Dai Y, Liu L, Zeng T, Liang JZ, Song Y, Chen K, Li Y, Chen L, Zhu YH, Li J, Li Y, Xie D, Yuan YF, Guan XY. Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma. Am J Pathol. 2018 Feb;188(2):378-391. (影响因子: 6.0)
  24. Jiang L, Yan Q, Fang S, Liu M, Li Y, Yuan YF, Li Y, Zhu Y, Qi J, Yang X, Kwong DLW, Guan XY. Calcium binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating ERK signaling pathway. Hepatology. 2017 Nov;66(5):1529-1545. (影响因子: 14.0)
  25. Chow RK, Sin ST, Liu M, Li Y, Chan TH, Song Y, Chen L, Kwong DL, Guan XY. AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways. Oncotarget. 2016 Oct 18;8(48):83469-83479.
  26. Liu M, Chen L, Ma NF, Chow RK, Li Y, Song Y, Chan TH, Fang S, Yang X, Xi S, Jiang L, Li Y, Zeng TT, Li Y, Yuan YF, Guan XY. CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors. Hepatology. 2016 May;63(5):1544-59. (影响因子: 14.0)
  27. Jiang L, Kwong DL, Li Y, Liu M, Yuan YF, Li Y, Fu L, Guan XY. HBP21, a chaperone of heat shock protein 70, functions as a tumor suppressor in hepatocellular carcinoma. Carcinogenesis. 2015 Oct;36(10):1111-20. (影响因子: 4.7)
  28. Song Y, Pan G, Chen L, Ma S, Zeng T, Chan HM, Li L, Lian Q, Chow R, Cai X, Li Y, Li Y, Liu M, Li Y, Zhu Y, Wong N, Yuan YF, Pei D, Guan XY. Loss of ATOH8 increases stem cell features of hepatocellular carcinoma cells. Gastroenterology. 2015 Oct;149(4):1068-81. (影响因子: 29.4)
  29. Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong KJ, Liu M, Song Y, Chow RK, Ng VH, Yuan YF, Tenen DG, Guan XY, Chen L. A disrupted RNA editing balance mediated by ADARs in human hepatocellular carcinoma. Gut. 2014 May;63(5):832-43. (影响因子: 4.0)
  30. Liu M, Li Y, Chen L, Chan TH, Song Y, Fu L, Zeng TT, Dai YD, Zhu YH, Li Y, Chen J, Yuan YF, Guan XY. Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma. Gastroenterology. 2014 Apr;146(4):1084-96. (影响因子: 29.4)
  31. Liu L, Dai Y, Chen J, Zeng T, Li Y, Chen L, Zhu YH, Li J, Li Y, Xie D, Yuan YF, Guan XY. Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition via Akt/GSK-3β/Snail signaling. Hepatology. 2014 Feb;59(2):531-43. (影响因子: 14.0)
  32. Liu M, Chen LL, Chan TH, Wang J, Li Y, Li Y, Zeng TT, Yuan YF, Guan XY. Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma. Hepatology. 2012;55:1754-65. (影响因子: 14.0)
  33. Kong KL, Kwong DL, Chan TH, Law SY, Chen L, Li Y, Qin YR, Guan XY. MicroRNA-375 inhibits tumor growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut. 2012 Jan;61(1):33-42. (影响因子: 24.5)
  34. Li J, Lau GK, Chen L, Dong SS, Lan HY, Huang XR, Li Y, Luk JM, Yuan YF, Guan XY. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One. 2011;6(7):e21816. (影响因子: 3.7)
  35. Tang DJ, Dong SS, Ma NF, Xie D, Chen LL, Fu L, Lau SH, Li Y, Li Y, Guan XY. Overexpression of EIF5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.  Hepatology. 2010 Apr;51(4):1255-63. (影响因子: 14.0)

新闻动态 更多新闻

  • 生物系学子再次摘得国际基因机器工程(iGEM)大赛金奖

    2019-11-11
  • 生物系组织“实验室开放日”活动

    2019-11-05
  • 开学季 !九月,献给生物系的所有学生

    2019-11-05

加入团队

南方科技大学李妍课题组(肿瘤细胞生物学/信息学方向)招聘研究助理(可转博)
工作地点: 深圳市南方科技大学
招聘部门:南方科技大学生物系李妍课题组
聘用岗位:研究助理1-2名
薪酬:7000元/月起,另含五险一金、奖金等
研究方向:
本课题组长期从事肿瘤遗传学/表观遗传学/表观转录组学调控研究,以多组学测序技术及高通量筛选技术为支撑,利用细胞及动物等为实验模型,研究病理条件下基因表达调控机制,具体包括:

利用KO小鼠模型建立肿瘤发病模型,用于研究肿瘤的发生、发展;
利用多种高通量测序技术(mRNA-seq, miRNA-seq, ATAC-seq和 Hi-C等),结合细胞及动物模型,研究基因调控及RNA转录后调控;
重点关注肿瘤干细胞、肿瘤微环境、肿瘤免疫调控等重要问题;

以上方向均有工作基础,欢迎联系讨论具体的课题内容
应聘条件:
1)在生物学、生物信息学、医学或相关专业领域已毕业或即将毕业的硕士;本科或硕士就读于一流高校/学科;本科(GPA≥3.0)或硕士(GPA≥3.0)。
2)具备细胞生物学、分子生物学、生物化学等生物学基础知识,愿意学习并能熟练掌握相关实验技术;或具备高通量测序数据的生物信息学分析经验,具有基础的编程能力。
3)具有较好英语阅读、书写能力,能在转博前通过英语六级、雅思或托福测试。
其他:具备进取心和责任感,做事认真、有条理、具团队合作精神;
发展前景:
1)表现优秀者可以申请南科大博士研究生项目。
2)深圳拥有庞大的企业群体,研发机构和科研院校,学习深造及工作机会多,聘期内表现突出者可优先推荐其他单位深造、工作或推荐到国外合作单位继续交流;
联系方式及应聘程序:
1、请将申请材料发至李妍: liy33@sustech.edu.cn,邮件标题请注明“XXX应聘研究助理”。电话: 0755-88018428;
申请材料包含以下资料:
(1)应聘申请,包括本人意愿、简单工作设想、预期目标;
(2)个人简历
2、个人简历将在筛选后及时安排面试。个人信息将严格保密,申请材料不获退还。
截止日期
长期有效,直到岗位招满为止。
 
 
 
 
 
查看更多

联系我们

联系地址

中国广东省深圳市南山区学苑大道1088号南方科技大学生物系

办公电话

0755-88018428

电子邮箱

liy33@sustech.edu.cn

Copyright © 2018 All Rights Reserved.